Overview

CYPRESS - CYPHER for Evaluating Sustained Safety

Status:
Unknown status

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

CYPRESS: A Prospective,Randomized,Multi-Center,Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER® Sirolimus-eluting Coronary Stent (CYPHER® Stent)

Phase:

Phase 4

Details

Lead Sponsor:

Cordis Corporation

Treatments:

Aspirin
Clopidogrel
Prasugrel Hydrochloride